Cancer Research and Treatment

Original Articles

Conditional Relative Survival and Competing Mortality in Surgically Treated Patients with Localized and Regional Kidney Cancer in Korea: A Nationwide Cohort Study: Hyun Bin Shin, Dong Wook Shin, In Young Cho, Junhee Park, Jung Jin Hyung, Kyungdo Han, Jinsung Park; Received May 24, 2025 Accepted March 5, 2026 Published online March 9, 2026; DOI: https://doi.org/10.4143/crt.2025.557 [Accepted]

Abstract PDF: Purpose
To investigate the 5-year conditional relative survival and competing mortality in surgically treated patients with localized and regional kidney cancer.
Materials and Methods
Using a nationwide population-based database, the Korea Clinical Data Utilization Network for Research Excellence, conditional relative survival conditioned on 1 to 3 years of survival after diagnosis was measured. These rates were stratified by age, sex, socioeconomic status, comorbidities, and treatment received. Cause of death and estimated cause-specific mortality were also described and considered with competing risks.
Results
This study included a total of 19,749 newly diagnosed patients with kidney cancer who underwent surgical treatment from 2013 to 2019. The baseline conditional relative survival rates for the entire cohort, patients with localized disease, and patients with regional disease were 97.2%, 99.4%, and 82.6%, respectively. After one year, these rates increased to 99.4%, 100.0%, and 95.3%, respectively. Patients who underwent surgery only had the highest baseline conditional relative survival rates (99.3%) compared with those who received surgery with radiotherapy (74.0%), with chemotherapy (38.9%), and with chemotherapy and radiotherapy (16.2%). Specifically, patients who underwent robotic surgery or partial nephrectomy showed higher baseline conditional relative survival rates (>100%) than others. Furthermore, kidney cancer was the leading cause of death (49.6%), followed by other types of cancer and cardiovascular disease. Over time, kidney cancer-specific mortality decreased.
Conclusion
Conditional survival after surgery for localized or regional kidney cancer was high and improved over time. These findings indicate that long-term prognosis varies by stage and patient characteristics and should inform postoperative surveillance.

611 View
17 Download

Smoking, Alcohol, and Abdominal Obesity Increase Gastric Cancer Risk after Helicobacter pylori Eradication: Joo Hyun Lim, Cheol Min Shin, Kyungdo Han, Jin-Hyung Jung, Jinju Choi, Eun Hyo Jin, Seung Joo Kang, Dong Ho Lee; Received November 3, 2025 Accepted December 30, 2025 Published online January 2, 2026; DOI: https://doi.org/10.4143/crt.2025.1200 [Epub ahead of print]

Abstract PDF: Purpose
Helicobacter pylori is the single most important risk factor for gastric cancer (GC). However, H. pylori eradication (HPE) does not eliminate risk of GC. To clarify the association of lifestyle factors with GC risk after HPE.
Materials and Methods
Using the Korean National Health Insurance Services (NHIS) database, adult individuals who claimed HPE between 2010 and 2016 were analyzed. The adjusted hazard ratios (aHR) for GC were analyzed according to the lifestyle status including smoking (never; light [<10PY]; moderate [10-20PY]; heavy [≥20PY]), alcohol (none; mild [<30g/day]; heavy [30g/day]), and abdominal obesity by using Cox proportional hazard model.
Results
During a median follow-up period of 6.7 years, 9,754 individuals were newly diagnosed with GC among the total of 1,282,702 subjects. Compared with never smokers, moderate (aHR, 1.12 [95% confidence interval (CI), 1.04 to 1.20]) and heavy smokers (1.34 [95% CI, 1.27 to 1.42]) had greater risks of post-HPE GC with dose-response manner. Heavy drinkers had increased risk of GC (1.23 [95% CI, 1.15 to 1.32]) compared with non-drinkers, and those with abdominal obesity had slightly elevated GC risk compared with those without that (1.11 [95% CI, 1.06 to 1.15]). In subgroup analyses, those who had HPE at age ≥ 55 were shown to be more affected by the unhealthy lifestyles (smoking [p-for-interaction < 0.001], alcohol [0.019], and abdominal obesity [0.024]). Also, male showed greater risk increase by smoking habit (p-for-interaction=0.022) than female.
Conclusion
Unhealthy lifestyles like smoking, alcohol, and abdominal obesity were shown as risk factors for post-HPE GC. Those with late HPE were more likely to be affected by unhealthy lifestyles.

1,260 View
50 Download

Skin cancer

Association between Obesity and Melanoma Risk in an Asian Population: A Nationwide Cohort Study: Hye Yeon Koo, Kyungdo Han, Jihye Park, Jinhyung Jung, Seonghye Kim, Hyeonjin Cho, In Young Cho, Dong Wook Shin; Cancer Res Treat. 2026;58(2):677-685. Published online June 18, 2025; DOI: https://doi.org/10.4143/crt.2025.169

Abstract PDF Supplementary Material PubReader ePub

Purpose
Previous studies from mostly Western populations have suggested possible associations between obesity and melanoma risk. This study aimed to investigate associations between obesity status and melanoma using a nationwide cohort of Koreans.
Materials and Methods
A total of 4,441,403 adults who received a national health examination in 2012 were included from the Korean National Health Insurance Service database, and followed until December 31, 2022. Obesity status was defined based on the body mass index at the baseline health examination. Cox proportional hazards analyses were performed to evaluate associations between obesity status and incident melanoma, with adjustment for confounders. Stratified analyses were performed by sex and menopausal status (in women).
Results
Overall, melanoma risk increased according to obesity status (p for trend=0.024); adjusted hazard ratios (95% confidence intervals) for melanoma risk were 0.766 (0.438–1.340) in underweight; 1.292 (1.072–1.557) in overweight; 1.202 (1.002–1.442) in obesity; and 1.191 (0.798–1.778) in severe obesity compared to normal weight (reference). In stratified analyses, similar trends to those of the overall study population were observed among men and premenopausal women (p for trend=0.052 in men and 0.036 in premenopausal women). Among premenopausal women, the risk of melanoma increased linearly with obesity status. Meanwhile, among postmenopausal women, melanoma risk showed no significant difference or trend according to obesity status.
Conclusion
Overweight and obesity were associated with increased risk of melanoma in a population-based cohort of Koreans. Obese individuals, especially men and premenopausal women, may require more thorough prevention and screening strategies for melanoma.

Citations

Citations to this article as recorded by

Obesity and Cancer: Mechanisms, Epidemiological Evidence, and Potential Risk Reduction
Jung-sun Lim, Seonghye Kim, In Young Cho, Dong Wook Shin
Journal of Obesity & Metabolic Syndrome.2026; 35(1): 14. CrossRef
Obesity and melanoma: unraveling the paradoxical survival benefit in immunotherapy
Junjie Yang, Qingqing Hu, Chunyu Xue
Cancer and Metastasis Reviews.2026;[Epub] CrossRef

2,551 View
65 Download
2 Web of Science
2 Crossref

Genitourinary cancer

Dose-Response Association between Alcohol Consumption and Kidney Cancer Risk Differs According to Glycemic Status: A Nationwide Cohort Study of 9.4 Million Individuals: Joo-Hyun Park, Jung Yong Hong, Kyungdo Han, Jay J. Shen, Se Hoon Park; Cancer Res Treat. 2025;57(4):1178-1186. Published online January 31, 2025; DOI: https://doi.org/10.4143/crt.2024.996

Abstract PDF Supplementary Material PubReader ePub

Purpose
Previous studies suggested an association between alcohol consumption and reduced kidney cancer risk. Given a potential interaction between alcohol’s insulin-sensitizing effect and hyperglycemia-related insulin resistance, we aimed to assess whether the dose-response association between alcohol intake and kidney cancer risk varies based on glycemic status.
Materials and Methods
This nationwide cohort study analyzed data from 9,492,331 adults who underwent a national health screening program in 2009 and were followed until 2018. Multivariable-adjusted Cox regression models were applied to estimate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs).
Results
Over a median follow-up period of 8.3 years, 12,381 participants were diagnosed with kidney cancer. A U-shaped relationship between alcohol consumption and kidney cancer risk was observed among individuals with normoglycemia (light-to-moderate: HR, 0.94; 95% CI, 0.89 to 0.99 and heavy: HR, 1.00; 95% CI, 0.91 to 1.09, respectively). In prediabetic individuals, alcohol consumption was not significantly associated with kidney cancer risk. In individuals with diabetes, a dose-dependent increase in kidney cancer risk was noted with higher alcohol consumption (light-to-moderate consumption: HR, 1.12; 95% CI, 1.03 to 1.22; heavy consumption: HR, 1.24; 95% CI, 1.09 to 1.42; p for trend < 0.01).
Conclusion
A modest U-shaped dose-response association between alcohol consumption and kidney cancer risk was observed exclusively in individuals with normoglycemia. Individuals with diabetes demonstrated a dose-dependent increased risk of kidney cancer with higher alcohol consumption. Tailored patient education and personalized risk assessments regarding alcohol consumption and kidney cancer risk should be emphasized over a generalized ‘one-size-fits-all’ approach.

Citations

Citations to this article as recorded by

Alcohol Consumption Trajectories from Early Adulthood to Adulthood and Cancer Risk in Adulthood: A Systematic Review and Meta-analysis
Samira Behboudi-Gandevani, Ingunn Jystad Brustad, Tommy Haugan, Vegar Rangul, Ellen Christin Arntzen, Marianne Sivertsen, Sarah Cook, Razieh Bidhendi-Yarandi
Cancer Epidemiology, Biomarkers & Prevention.2026; 35(6): 824. CrossRef

6,023 View
137 Download
1 Web of Science
1 Crossref

Breast cancer

Novel Breast Cancer Risk Assessment Tools for Pre- and Postmenopausal Asian Women: Development and Validation in a Nationwide Mammographic Screening Cohort: Wonyoung Jung, Yong-Moon Mark Park, Sang Hyun Park, Kyungdo Han, Junhee Park, Yohwan Yeo, Jung Kwon Lee, Dale P. Sandler, Dong Wook Shin; Cancer Res Treat. 2025;57(4):1051-1063. Published online January 31, 2025; DOI: https://doi.org/10.4143/crt.2024.861

Abstract PDF Supplementary Material PubReader ePub: Purpose
Widely used breast cancer risk-prediction tools are based on data from Western countries, but risk factors may differ for Asian women. Hence, we aimed to develop a risk assessment tool for breast cancer in Asian women using a nationwide, population-based mammographic screening cohort.
Materials and Methods
Women aged ≥ 40 years who underwent breast cancer screening and general health examination in 2009 were included. Age, body mass index (BMI), breast density, lifestyle and reproductive factors, and comorbidities were used to develop 5-year breast cancer risk-prediction models for premenopausal (n=771,856) and postmenopausal (n=1,108,047) women at baseline. The best-fit risk prediction model was constructed using backward stepwise selection in a Cox proportional hazards model and was transformed into a risk score nomogram. The performance was assessed by discrimination and calibration.
Results
In premenopausal women, high BMI, low parity, short breastfeeding period, early age at menarche, high breast density, a history of benign breast masses, and family history of breast cancer contributed to the risk prediction of breast cancer. In postmenopausal women, age, diabetes mellitus, dyslipidemia, late-onset menopause, and hormone replacement therapy use were additional risk predictors of breast cancer. Our risk-prediction model showed a concordant statistic of 0.58 (0.57-0.59) for premenopausal women and 0.64 (0.63-0.65) for postmenopausal women. The calibration plot demonstrated good correlations for both models.
Conclusion
Our breast cancer risk-prediction model demonstrated performance comparable to that of Western countries, especially among postmenopausal women. This provides a foundation for implementing risk-based screening recommendations in Asian women.

4,172 View
155 Download

General

Weight Change after Cancer Diagnosis and Risk of Diabetes Mellitus: A Population-Based Nationwide Study: Hye Yeon Koo, Kyungdo Han, Mi Hee Cho, Wonyoung Jung, Jinhyung Jung, In Young Cho, Dong Wook Shin; Cancer Res Treat. 2025;57(2):339-349. Published online August 29, 2024; DOI: https://doi.org/10.4143/crt.2024.586

Abstract PDF Supplementary Material PubReader ePub

Purpose
Cancer survivors are at increased risk of diabetes mellitus (DM). Additionally, the prevalence of obesity, which is also a risk factor for DM, is increasing in cancer survivors. We investigated the associations between weight change after cancer diagnosis and DM risk.
Materials and Methods
This retrospective cohort study used data from the Korean National Health Insurance Service. Participants who were newly diagnosed with cancer from 2010 to 2016 and received national health screening before and after diagnosis were included and followed until 2019. Weight change status after cancer diagnosis was categorized into four groups: sustained normal weight, obese to normal weight, normal weight to obese, or sustained obese. Cox proportional hazard analyses were performed to examine associations between weight change and DM.
Results
The study population comprised 264,250 cancer survivors. DM risk was highest in sustained obese (adjusted hazard ratios [aHR], 2.17; 95% confidence interval [CI], 2.08 to 2.26), followed by normal weight to obese (aHR, 1.66; 95% CI, 1.54 to 1.79), obese to normal weight (aHR, 1.29; 95% CI, 1.21 to 1.39), and then sustained normal weight group (reference). In subgroup analyses according to cancer type, most cancers showed the highest risks in sustained obese group.
Conclusion
Obesity at any time point was related to increased DM risk, presenting the highest risk in cancer survivors with sustained obesity. Survivors who changed from obese to normal weight had lower risk than survivors with sustained obesity. Survivors who changed from normal weight to obese showed increased risk compared to those who sustained normal weight. Our finding supports the significance of weight management among cancer survivors.

Citations

Citations to this article as recorded by

New‐onset prediabetes/diabetes worsens overall survival in patients with cancer: A real‐world retrospective cohort study
Maci Winn, Svenja Pauleck, Stephanie Richardson, Richard Viskochil, Prasoona Karra, Howard Colman, Jennifer A. Doherty, Yizhe Xu, Siwen Hu‐Lieskovan, Michelle Litchman, Mary C. Playdon, Sheetal Hardikar
Diabetes, Obesity and Metabolism.2026; 28(2): 1247. CrossRef
Risk of Newly Incident Diabetes Mellitus and Treatment Risk Factors in Breast Cancer Survivors: Landmark Analyses of Nationwide Data
Hyeongjin Shim, Bong-seong Kim, Kyungdo Han, Hye Yeon Koo, Seonghye Kim, Dagyeong Lee, In Young Cho, Wonyoung Jung, Dong Wook Shin
Asia Pacific Journal of Public Health.2026; 38(4): 265. CrossRef
Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study
MI Hee Cho, Jinhyung Jung, Hye Yeon Koo, Wonyoung Jung, Kyungdo Han, In Young Cho, Dong Wook Shin
Diabetes & Metabolism.2025; 51(1): 101604. CrossRef

4,544 View
159 Download
3 Web of Science
3 Crossref

Gastrointestinal cancer

The Persistence of Hypertriglyceridemia and the Risk of Early Onset Colorectal Cancer According to Tumor Subsites: A Nationwide Population-Based Study: Young Hoon Chang, Cheol Min Shin, Kyungdo Han, Jin Hyung Jung, Eun Hyo Jin, Joo Hyun Lim, Seung Joo Kang, Yoon Jin Choi, Hyuk Yoon, Young Soo Park, Nayoung Kim, Dong Ho Lee; Cancer Res Treat. 2024;56(3):825-837. Published online December 20, 2023; DOI: https://doi.org/10.4143/crt.2023.753

Abstract PDF Supplementary Material PubReader ePub

Purpose
The incidence of early-onset colorectal cancer (EoCRC) is increasing worldwide. The association between hypertriglyceridemia (HTG) and EoCRC risk remains unclear.
Materials and Methods
We conducted a nationwide cohort study of 3,340,635 individuals aged 20-49 years who underwent health checkups between 2009 and 2011 under the Korean National Health Insurance Service. HTG was defined as serum triglyceride (TG) level ≥ 150 mg/dL. According to the change in TG status, participants were categorized into persistent normotriglyceridemia (NTG; group 1), NTG to HTG (group 2), HTG to NTG (group 3), and persistent HTG (group 4) groups. The EoCRC incidence was followed up until 2019.
Results
In total, 7,492 EoCRC cases developed after a mean of 6.05 years of follow-up. Group 4 had the highest risk of EoCRC (adjusted hazard ratio [aHR], 1.097; 95% confidence interval [CI], 1.025 to 1.174). While the risk of rectal cancer was significantly increased in groups 3 and 4 (aHR [95% CI], 1.236 [1.076 to 1.419] and 1.175 [1.042-1.325], respectively), no significant risk differences were observed in right colon cancer. In group 4, male sex and diabetes were associated with a further increased risk of EoCRC (aHR [95% CI], 1.149 [1.082 to 1.221] and 1.409 [1.169 to 1.699], respectively). In addition, there was a dose-response relationship between serum TG levels and the risk of EoCRC (p for trends < 0.0001).
Conclusion
Persistent HTG increased the risk of EoCRC, which was significantly higher only for rectal cancer and marginally higher for other colonic subsites.

Citations

Citations to this article as recorded by

The association between serum triglycerides and colorectal cancer incidence in community-dwelling middle-aged and older adults in Korea: a secondary analysis of a community-based prospective cohort
Bo-Kyoung Cha
Journal of Korean Biological Nursing Science.2026; 28(1): 119. CrossRef
Systemic inflammation mediates the link between metabolic syndrome and colorectal cancer risk: insights from a large prospective cohort
Wenwen Lv, Suna Wang, Lei Duan, Zhongxun Dong, Hai Zhu, Gang Wang, Zhangsheng Yu, Shuhua Xu
Postgraduate Medical Journal.2026;[Epub] CrossRef
Risk Factors for Early-Onset Colorectal Cancer: A Nested Case‒Control Study within the Korean National Health Insurance Service‒Health Screening Cohort
Ji Yoon Baek, Seung-Yong Jeong, Aesun Shin
Cancer Epidemiology, Biomarkers & Prevention.2026; 35(4): 647. CrossRef
High-fat diet, triglyceride glucose index, and gastrointestinal cancer: integrative insights from human and animal studies
Jinmei Li, Zi Dai, Yinping Cai, Ye Wu, Yalan Wu, Cantu Fang, Yao Wang
Frontiers in Nutrition.2026;[Epub] CrossRef
Risk Factors in Sporadic Early-Onset Colorectal Cancer, Current Evidence and Emerging Insights: A Systematic Review
Meghana Maddula, Jordan E. Cohen, Dulitha Kumarasinghe, Mandy L. Ballinger, Jaqueline L. E. Tearle, Kylie R. James, Adnan Nagrial, Megan Barnet, Subotheni Thavaneswaran
Cancers.2026; 18(10): 1515. CrossRef
Association between remnant cholesterol and advanced colorectal adenoma in individuals under 50 years of age
Kwangmin Joo, Jong Yoon Lee, Jong Hoon Lee
Intestinal Research.2026;[Epub] CrossRef
The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy
Elena Crecca, Gianfranco Di Giuseppe, Claudia Camplone, Virginia Vigiano Benedetti, Ombretta Melaiu, Teresa Mezza, Chiara Cencioni, Francesco Spallotta
Pharmacology & Therapeutics.2025; 270: 108847. CrossRef
Obesity-Associated Colorectal Cancer
Lucia Gonzalez-Gutierrez, Omar Motiño, Daniel Barriuso, Juan de la Puente-Aldea, Lucia Alvarez-Frutos, Guido Kroemer, Roberto Palacios-Ramirez, Laura Senovilla
International Journal of Molecular Sciences.2024; 25(16): 8836. CrossRef

6,851 View
143 Download
7 Web of Science
8 Crossref

Hematologic malignancy

Association between Kidney Function, Proteinuria and the Risk of Multiple Myeloma: A Population-Based Retrospective Cohort Study in South Korea: Taewoong Choi, Wooin Ahn, Dong Wook Shin, Kyungdo Han, Dahye Kim, Sohyun Chun; Cancer Res Treat. 2022;54(3):926-936. Published online September 27, 2021; DOI: https://doi.org/10.4143/crt.2021.951

Abstract PDF Supplementary Material PubReader ePub

Purpose
While renal impairment is one of the first clinical manifestations of multiple myeloma (MM), declined renal function may conversely be a risk factor for cancers including MM. In this study, we investigated the relationship between chronic kidney disease and MM at a population level.
Materials and Methods
A total of 9,809,376 adults who participated in a nationwide health screening program and had no MM, cancer or end-stage renal disease at baseline were investigated for incidence of MM. The impact of estimated glomerular filtration rate (eGFR) and random urine dipstick proteinuria, and interactive associations of the two factors on the MM incidence were evaluated.
Results
The general incidence of MM was 4.8 per 100,000 person-years (mean follow-up of 8.3 years). Participants with eGFR < 60 mL/min/1.73 m² (5.8% of participants) had higher MM incidence than those with eGFR ≥ 60 mL/min/1.73 m² (adjusted hazard ratio, 1.29; 95% confidence interval, 1.17 to 1.43). When eGFR was graded into five levels, there was a significant inverse dose-response relationship between eGFR level and MM incidence at the lower eGFR levels (reference: eGFR 60-89 mL/min/1.73 m²). A dose-response relationship was also found with degree of dipstick proteinuria and incidence of MM.
Conclusion
Adults with decreased renal function indicated either by decreased eGFR or presence of proteinuria are at a higher risk of developing MM compared to those without, and there is a dose-response relationship between the severity of renal impairment and MM incidence.

Citations

Citations to this article as recorded by

Silymarin induces multiple myeloma cell apoptosis by inhibiting the JAK2/STAT3 signaling pathway
Haiyun Liu, Tingting Liu, Junquan Zeng, Quangang Fang
Oncology Letters.2025; 30(3): 1. CrossRef
End-stage renal diseases associated with SGLT2 inhibitors versus GLP-1 receptor agonists in metabolic dysfunction-associated steatotic liver disease
Hwa Yeon Ko, Bin Hong, Sungho Bea, Jae Hyun Bae, Young Min Cho, Yoosoo Chang, Seungho Ryu, Christopher D Byrne, Ju-Young Shin
Diabetes Research and Clinical Practice.2025; 229: 112921. CrossRef
Quantitative risk factor analysis of prior disease condition and socioeconomic status with the multiple myeloma development: nationwide cohort study
Suein Choi, Eunjin Kim, Jinhee Jung, Sung-Soo Park, Chang-Ki Min, Seunghoon Han
Scientific Reports.2024;[Epub] CrossRef

11,542 View
163 Download
3 Web of Science
3 Crossref

Disparities in the Participation Rate of Colorectal Cancer Screening by Fecal Occult Blood Test among People with Disabilities: A National Database Study in South Korea: Dong Wook Shin, Dongkyung Chang, Jin Hyung Jung, Kyungdo Han, So Young Kim, Kui Son Choi, Won Chul Lee, Jong Heon Park, Jong Hyock Park; Cancer Res Treat. 2020;52(1):60-73. Published online May 7, 2019; DOI: https://doi.org/10.4143/crt.2018.660

Abstract PDF Supplementary Material PubReader ePub

Purpose
Implementation of screening program may lead to increased health disparity within the population if participation differs by socioeconomic status. In Korea, colorectal cancer screening is provided at no or minimal cost to all people over 50 by National Cancer Screening Program. We investigated colorectal cancer screening participation rate and its trend over the last 10 years in relation to disabilities.
Materials and Methods
We linked national disability registration data with National Cancer Screening Program data. Age, sex-standardized participation rates were analyzed by type and severity of disability for each year, and factors associated with colorectal cancer screening participation were examined by multivariate logistic regression.
Results
Age, sex-standardized participation rate in people without disability increased from 16.2 to 33.9% (change, +17.7), but it increased from 12.7% to 27.2% (change, +14.5) among people with severe disability. People with severe disabilities showed a markedly lower colorectal cancer screening participation rate than people without disability (adjusted odds ratio [aOR], 0.714; 95% confidence interval, 0.713 to 0.720). People with autism (aOR, 0.468), renal failure (aOR, 0.498), brain injury (aOR, 0.581), ostomy (aOR, 0.602), and intellectual disability (aOR, 0.610) showed the lowest participation rates.
Conclusion
Despite the availability of a National Cancer Screening Program and overall increase of its usage in the Korean population, a significant disparity was found in colorectal cancer screening participation, especially in people with severe disabilities and or several specific types of disabilities. Greater effort is needed to identify the barriers faced by these particularly vulnerable groups and develop targeted interventions to reduce inequality.

Citations

Citations to this article as recorded by

Cervical Cancer Screening and Prevention Uptake in Females with Autism Spectrum Disorder
Yachin Chen, James Powers, Christopher J. McDougle, Nicole R. Zürcher, Robyn P. Thom
Journal of Autism and Developmental Disorders.2026; 56(1): 1. CrossRef
Colorectal Cancer Screening Among People With Intellectual Disabilities
Trine Allerslev Horsbøl, Susan Ishøy Michelsen, Trine Toft Sørensen, Knud Juel, Morten Rasmussen, Ismail Gögenur, Susanne Oksbjerg Dalton, Amina Banda, Maarten Cuypers, Lau Caspar Thygesen
JAMA Network Open.2026; 9(1): e2557013. CrossRef
Trends in uptake of cancer screening among people with severe mental illness before and after the COVID‐19 pandemic in Japan: A repeated cross‐sectional study
Yuto Yamada, Masaki Fujiwara, Naoki Nakaya, Koji Otsuki, Taichi Shimazu, Maiko Fujimori, Shiro Hinotsu, Kiwamu Nagoshi, Yosuke Uchitomi, Masatoshi Inagaki
Psychiatry and Clinical Neurosciences Reports.2025;[Epub] CrossRef
Health inequities among persons with disabilities: a global scoping review
Emre Umucu, Andrew A. Vernon, Deyu Pan, Sang Qin, Guillermina Solis, Rebecca Campa, Beatrice Lee
Frontiers in Public Health.2025;[Epub] CrossRef
Cancer screening participation and outcomes among people with an intellectual disability in the Netherlands: a cross-sectional population-based study
Amina Banda, Maarten Cuypers, Jenneken Naaldenberg, Aura Timen, Geraline Leusink
The Lancet Public Health.2025; 10(3): e237. CrossRef
Enhancing doxorubicin's anticancer impact in colorectal cancer by targeting the Akt/Gsk3β/mTOR-SREBP1 signaling axis with an HDAC inhibitor
Huaxin Zhao, Yanling Wu, Soo Mi Kim
The Korean Journal of Physiology & Pharmacology.2025; 29(3): 321. CrossRef
Cancer inequalities experienced by people with disability: a systematic review
Yi Yang, Nina Afshar, Joanna Butchart, Alex Sully, Rebecca J. Bergin, Anne Kavanagh, George Disney
Disability and Health Journal.2025; 18(4): 101851. CrossRef
Cancer prevalence and care disparities among individuals with intellectual disabilities: a cross-sectional pan-cancer analysis
T. Sappok, M.-L. Rosenbusch, R. Hering, M. Schulz, C. Kowalski, N.T. Sibert, T. Seufferlein, A.W. Berger
ESMO Real World Data and Digital Oncology.2025; 9: 100160. CrossRef
Barriers to cancer screening uptake and approaches to overcome them: a systematic literature review
R. Aguiar-Ibáñez, YPV. Mbous, Sugandh Sharma, R. Chakali, E. Chawla
Frontiers in Oncology.2025;[Epub] CrossRef
Disability-Related Disparities in Preventive Healthcare Access in South Korea: Insights From National Health Insurance Data
Sujin Kim, Boyoung Jeon
International Journal of Public Health.2025;[Epub] CrossRef
Long-Term Cancer Incidence Trends in Korea (2001–2020): An Age–Period–Cohort and Joinpoint Analysis with a Focus on Younger Cohorts
Hyungho Lee, Mingyu Kim, Geehyun Song, Jae Young Joung, Hokyung Seo, Jin-Ha Yoon, Jinsoo Chung
Medicina.2025; 61(12): 2179. CrossRef
Comparative analysis of genetic testing utilization rates among people with and without disabilities in South Korea from 2016 to 2019, focusing on malignant neoplasms: A national population‐based study
Gwanwook Bang, Minji Park, Jeong‐yeon Seon, So‐Youn Park
Cancer Medicine.2024;[Epub] CrossRef
Disparities in the diagnosis and treatment of colorectal cancer among patients with disabilities
Ki Bae Kim, Dong Wook Shin, Kyoung Eun Yeob, So Young Kim, Joung-Ho Han, Seon Mee Park, Jong Heon Park, Jong Hyock Park
World Journal of Gastrointestinal Oncology.2024; 16(7): 2925. CrossRef
The effect of the expansion of the Personal Assistance Service Program on the uptake of the National Health Screening in people with severe disability
Woorim Kim, Mingee Choi, Jaeyong Shin
Journal of Public Health.2024; 46(4): 537. CrossRef
Disability and Participation in Colorectal Cancer Screening: A Systematic Review and Meta-Analysis
Giovanni Emanuele Ricciardi, Rita Cuciniello, Emanuele De Ponti, Carlo Lunetti, Flavia Pennisi, Carlo Signorelli, Cristina Renzi
Current Oncology.2024; 31(11): 7023. CrossRef
Family physicians’ and trainees’ experiences regarding cancer screening with patients with intellectual disability: An interpretive description study
Genevieve Breau, Sally Thorne, Jennifer Baumbusch, T Greg Hislop, Arminee Kazanjian
Journal of Intellectual Disabilities.2023; 27(1): 250. CrossRef
Type and Severity of Mental Illness and Participation in Colorectal Cancer Screening
Benedicte Kirkøen, Paula Berstad, Geir Hoff, Tomm Bernklev, Kristin R. Randel, Øyvind Holme, Thomas de Lange, Kathryn A. Robb, Edoardo Botteri
American Journal of Preventive Medicine.2023; 64(1): 76. CrossRef
Spatial and temporal patterns of colorectal cancer in Asia, 1990–2019
Rajesh Sharma, Bijoy Rakshit
International Journal of Clinical Oncology.2023; 28(2): 255. CrossRef
Uptake patterns and predictors of colorectal cancer screening among adults resident in Spain: A population-based study from 2017 to 2020
Silvia Portero de la Cruz, Jesús Cebrino
Frontiers in Public Health.2023;[Epub] CrossRef
The Korea National Disability Registration System
Miso Kim, Wonyoung Jung, So Young Kim, Jong Hyock Park, Dong Wook Shin
Epidemiology and Health.2023; 45: e2023053. CrossRef
Assessing cancer in people with profound and multiple disabilities
Daniel Satgé, Motoi Nishi, Brigitte Trétarre
BMC Cancer.2023;[Epub] CrossRef
Cancer detection, diagnosis, and treatment for adults with disabilities
Lisa I Iezzoni
The Lancet Oncology.2022; 23(4): e164. CrossRef
Mental illness and participation in colorectal cancer screening: a scoping review
Marie D. Jørgensen, Ellen M. Mikkelsen, Rune Erichsen, Mette K. Thomsen
Scandinavian Journal of Gastroenterology.2022; 57(10): 1216. CrossRef
Patients’ acceptability and implementation outcomes of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia: a qualitative secondary analysis of a mixed-method randomised clinical trial
Yuto Yamada, Masaki Fujiwara, Taichi Shimazu, Tsuyoshi Etoh, Masafumi Kodama, Ryuhei So, Takanori Matsushita, Yusaku Yoshimura, Shigeo Horii, Maiko Fujimori, Hirokazu Takahashi, Naoki Nakaya, Tempei Miyaji, Shiro Hinotsu, Keita Harada, Hiroyuki Okada, Yos
BMJ Open.2022; 12(6): e060621. CrossRef
Disability and Participation in Breast and Cervical Cancer Screening: A Systematic Review and Meta-Analysis
Fahrin Ramadan Andiwijaya, Calum Davey, Khaoula Bessame, Abdourahmane Ndong, Hannah Kuper
International Journal of Environmental Research and Public Health.2022; 19(15): 9465. CrossRef
Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway
Dan Hu, Ruo Meng, Thi Nguyen, Ok Chai, Byung Park, Ju-Seog Lee, Soo Kim
Molecular Medicine Reports.2022;[Epub] CrossRef
The Role of Disability Acceptance and Emotional Support in the Association between Negative Experiences and Depression in Disabled People with Cancer: A Moderated Mediation Model
Young Won Shin, Min Jin Jin, Myoung-Ho Hyun
STRESS.2022; 30(4): 244. CrossRef
Evaluation of health belief model-based educational intervention on colorectal cancer screening behavior at South Khorasan, Iran
Shahrbanoo Khazaei, Fatemeh Salmani, Mitra Moodi
Journal of Education and Health Promotion.2022;[Epub] CrossRef
Time trends of colorectal cancer incidence and associated lifestyle factors in South Korea
Hayeong Khil, Sung Min Kim, SungEun Hong, Hyeon Min Gil, Eugene Cheon, Dong Hoon Lee, Young Ae Kim, NaNa Keum
Scientific Reports.2021;[Epub] CrossRef
Disparities in Liver Cancer Surveillance Among People With Disabilities
Jae Youn Seo, Dong Wook Shin, Su Jong Yu, Jin Hyung Jung, Kyungdo Han, In Young Cho, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
Journal of Clinical Gastroenterology.2021; 55(5): 439. CrossRef
Do cholesterol levels and continuity of statin use affect colorectal cancer incidence in older adults under 75 years of age?
Kyu-Tae Han, Seungju Kim, Antonio Palazón-Bru
PLOS ONE.2021; 16(4): e0250716. CrossRef
Disparities in prostate cancer diagnosis, treatment, and survival among men with disabilities: Retrospective cohort study in South Korea
Dong Wook Shin, Jinsung Park, Kyoung Eun Yeob, Seok Jung Yoon, Soong-nang Jang, So Young Kim, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
Disability and Health Journal.2021; 14(4): 101125. CrossRef
Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial
Masaki Fujiwara, Yuto Yamada, Taichi Shimazu, Masafumi Kodama, Ryuhei So, Takanori Matsushita, Yusaku Yoshimura, Shigeo Horii, Maiko Fujimori, Hirokazu Takahashi, Naoki Nakaya, Kyoko Kakeda, Tempei Miyaji, Shiro Hinotsu, Keita Harada, Hiroyuki Okada, Yosu
Acta Psychiatrica Scandinavica.2021; 144(4): 318. CrossRef
Population-Based Data Reveal Factors Associated with Organised and Non-Organised Colorectal Cancer Screening: An Important Step towards Improving Coverage
Thuy Ngan Tran, Guido Van Hal, Marc Peeters, Svetlana Jidkova, Harlinde De Schutter, Sarah Hoeck
International Journal of Environmental Research and Public Health.2021; 18(16): 8373. CrossRef
Disparities in the Diagnosis, Treatment, and Survival Rate of Cervical Cancer among Women with and without Disabilities
Jin Young Choi, Kyoung Eun Yeob, Seung Hwa Hong, So Young Kim, Eun-Hwan Jeong, Dong Wook Shin, Jong Heon Park, Gil-won Kang, Hak Soon Kim, Jong Hyock Park, Ichiro Kawachi
Cancer Control.2021;[Epub] CrossRef
Disparities in gastric cancer screening among people with disabilities: a national registry-linkage study in South Korea
YoungJee Kim, Dong Wook Shin, Hyoung Woo Kim, Jin Hyung Jung, Kyungdo Han, In Young Cho, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
Gastric Cancer.2020; 23(3): 497. CrossRef
Disparities in the Diagnosis and Treatment of Gastric Cancer in Relation to Disabilities
Hyoung Woo Kim, Dong Wook Shin, Kyoung Eun Yeob, In Young Cho, So Young Kim, Seon Mee Park, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
Clinical and Translational Gastroenterology.2020; 11(10): e00242. CrossRef
Trends in cancer screening rates among individuals with serious psychological distress: an analysis of data from 2007 to 2016 Japanese national surveys
Masaki Fujiwara, Yuji Higuchi, Naoki Nakaya, Maiko Fujimori, Yuto Yamada, Riho Wada, Tsuyoshi Etoh, Kyoko Kakeda, Yosuke Uchitomi, Tomio Nakayama, Norihito Yamada, Masatoshi Inagaki
Journal of Psychosocial Oncology Research & Practice.2020; 2(3): e025. CrossRef

13,083 View
264 Download
34 Web of Science
38 Crossref

First
Prev
Page of 1
Next
Last

Search